Latest Health News

QBE Insurance Group has finalised the resale and buyback of its US$400 million perpetual capital notes, leading to their cancellation and delisting from the Singapore Exchange.

Aspen Group has offloaded its remaining stake in Eureka Group Holdings for $27.5 million, using the proceeds to significantly reduce its net debt while maintaining its FY25 earnings guidance.

Vitura Health’s joint venture Flora Holdings has acquired Heyday Medical Clinic, a leading medicinal cannabis provider, enhancing its national clinical network and patient access across Australia.

Bank of Queensland Limited has announced a fully franked quarterly distribution of AUD 1.3408 per Capital Note security, reflecting a stable income stream for investors tied to the 3-month BBSW plus margin.

Mount Burgess Mining announces the immediate resignation of long-serving Chairman Nigel Forrester due to ill health, appointing Dr. Steve Lennon as the new Executive Chairman to steer the company forward.

Recce Pharmaceuticals has successfully raised A$8.4 million through an entitlement offer and placement to fund pivotal Phase 3 clinical trials, advancing its synthetic anti-infective pipeline towards commercialisation in 2026.

dusk Group Limited reports a solid FY25 trading update with increased sales and EBIT, while navigating a slight dip in gross profit margin as it advances its product-led turnaround strategy.

Mayne Pharma Group has proposed a $7.40 per share acquisition by Cosette Pharmaceuticals, with unanimous board support and a fair and reasonable opinion from an independent expert. Shareholders will vote on the scheme on June 18, 2025.

Heavy Minerals Limited attributes its recent share price jump to media coverage about its upcoming Port Gregory Pre-Feasibility Study and confirms compliance with ASX disclosure rules.

HITIQ Limited has announced a non-renounceable entitlement offer to raise up to $2.92 million, supported by partial underwriting from GBA Capital and accompanied by new options issuance. The capital raise aims to fund expansion, product development, and operational growth.

Proteomics International Laboratories has secured a key Chinese patent for its OxiDx oxidative stress test, broadening its intellectual property coverage across major global markets until 2039. This milestone reinforces the company’s position in precision diagnostics for sports and veterinary health.

GrainCorp Limited has announced a combined ordinary and special dividend of AUD 0.24 per share, fully franked, reflecting steady returns for shareholders for the first half of 2025.